PRADER-WILLI SYNDROME
Clinical trials for PRADER-WILLI SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PRADER-WILLI SYNDROME trials appear
Sign up with your email to follow new studies for PRADER-WILLI SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug safety check for rare genetic condition
Disease control ENROLLING_BY_INVITATIONThis study looks at how safe the drug pitolisant is for 150 people with Prader-Willi syndrome who have already taken it in a previous study. Researchers will track any side effects that happen during treatment and for 30 days after the last dose. The goal is to make sure the drug…
Matched conditions: PRADER-WILLI SYNDROME
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Disease control
Last updated May 01, 2026 15:56 UTC
-
New study tracks safety of VYKAT XR in Prader-Willi patients
Disease control ENROLLING_BY_INVITATIONThis study watches about 200 people with Prader-Willi syndrome who are taking or starting VYKAT XR. Researchers want to see how safe the drug is and how patients do over time. The goal is to learn more about side effects and health outcomes, not to test if the drug works.
Matched conditions: PRADER-WILLI SYNDROME
Sponsor: Soleno Therapeutics, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC